Results of 18F-FDG PET/CT and Response to BT Injection Therapy
| Position during 18F-FDG uptake period | Hypermetabolic muscles (maximum SUV) | Tsui Scale score, initial/follow-up (% reduction) | TWSTRS | |||
|---|---|---|---|---|---|---|
| Patient | BT injected | BT not injected | Severity score, initial/follow-up (% reduction) | Disability score, initial/follow-up (% reduction) | ||
| 1 | Supine | i OCI (9.3), i SPC (8.2), i LGC (6.1), i SPc (4.0), c SCM (5.0) | i LC (6.7), i ScM (3.6), i ScP (2.6), c OCS (7.7), c RCPM (7.7), c SSC (5.0), c SSc (4.3), c uTz (3.2) | 9/0 (100) | 19/0 (100) | 21/0 (100) |
| 2 | Supine | i OCI (9.2), i ScP (5.1), i LGC (3.0) | i LC (4.8), i RCPm (3.6), i SPC (3.8), i SPc (3.0), c OCS (8.0), c RCPM (5.6), c SSC (4.2), c SSc (4.2) | 10/2 (80) | 23/12 (57) | 21/3 (86) |
| 3 | Supine | i Lc (6.8), i OCI (2.8), i SPC (2.3) | i LC (8.2), i RCPM (3.7) | 7/2 (71) | 20/8 (60) | 17/3 (82) |
| 4 | Supine | − | − | 6/NA (NA) | 15/NA (NA) | 18/NA (NA) |
| Sitting | − | i LC (8.1), i OCI (5.9), i SPC (3.7), c OCS (7.0), c SCM (5.6), c SSc (4.8), c TPV (4.0) | ||||
| 5 | Supine | − | − | 14/3 (79) | 23/3 (87) | 20/9 (55) |
| Sitting | i Lc (15.9), i OCI (6.9), i SPC (6.6), i LGC (6.0), i SPc (3.5), c SCM (6.9) | i LC (15.9), i RCPM (7.5), c SSc (6.4), c uTz (4.1), c OCS (3.1) | ||||
| 6 | Sitting | − | i LC (7.4), i ScP (5.6), i LGC (5.0), i SPC (4.7), i OCI (4.7), c OCS (3.7), c SCM (3.1) | 14/NA (NA) | 26/NA (NA) | 23/NA (NA) |
i = ipsilateral; OCI = obliquus capitis inferior; SPC = splenius capitis; LGC = longissimus capitis; SPc = splenius cervicis; c = contralateral; SCM = sternocleidomastoid; LC = longus capitis; ScM = scalenius medius; ScP = scalenius posterior; OCS = obliquus capitis superior; RCPM = rectus capitis posterior major; SSC = semispinalis capitis; SSc = semispinalis cervicis; uTz = upper trapezius; RCPm = rectus capitis posterior minor; Lc = longus colli; − = negative; NA = not applicable; TPV = upper thoracic paravertebral.